Remedium Lifecare Ltd — Updates, 08-04-2025: Company Update

Remedium Lifecare Ltd. has announced a board meeting to discuss a ₹49.19 Cr rights issue aimed at bolstering its growth capital. The company plans to use the funds for working capital, R&D equipment, and expansion. Shareholders will have the opportunity to subscribe to 49,19,04,000 shares at ₹1.00 each, with a rights ratio of 61 shares for every 50 held as of the record date of April 15, 2025. This initiative is timely as the company recently secured a significant multi-year export contract valued at ₹182.7 Cr, positioning it well for growth in international markets. Investors may view this rights issue as a positive outlook for financial stability and expansion strategy.